Insmed (NASDAQ:INSM) reported quarterly earnings results on February 19, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $-1.54, missing the consensus estimate of $-1.13 by $0.41 per share. Revenue came in at $263.8M, missing the estimate of $263.9M.
Insmed's stock moved following the earnings release. The stock currently trades at $161.69 with a market capitalization of $41.6B.


